SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-068359
Filing Date
2023-08-17
Accepted
2023-08-17 08:33:00
Documents
19
Period of Report
2023-08-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea183745-8k_abvcbio.htm   iXBRL 8-K 30395
2 THE COLLABORATION AGREEMENT DATED AUGUST 14, 2023 ea183745ex10-1_abvcbio.htm EX-10.1 33072
3 PRESS RELEASE DATED AUGUST 17, 2023 ea183745ex99-1_abvcbio.htm EX-99.1 8776
4 GRAPHIC image_001.jpg GRAPHIC 6862
5 GRAPHIC ex10-1_001.jpg GRAPHIC 43589
6 GRAPHIC ex10-1_002.jpg GRAPHIC 84113
7 GRAPHIC ex10-1_003.jpg GRAPHIC 97768
8 GRAPHIC ex10-1_004.jpg GRAPHIC 39617
  Complete submission text file 0001213900-23-068359.txt   632445

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE abvc-20230814.xsd EX-101.SCH 3021
10 XBRL LABEL FILE abvc-20230814_lab.xml EX-101.LAB 34240
11 XBRL PRESENTATION FILE abvc-20230814_pre.xml EX-101.PRE 22363
13 EXTRACTED XBRL INSTANCE DOCUMENT ea183745-8k_abvcbio_htm.xml XML 3216
Mailing Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538
Business Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538 510-668-0881
ABVC BIOPHARMA, INC. (Filer) CIK: 0001173313 (see all company filings)

IRS No.: 260014658 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40700 | Film No.: 231179881
SIC: 2834 Pharmaceutical Preparations